Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 9/20 | 0.45 |
| ▸ | NPY1R | P25929 | 5/20 | 0.45 |
| ▸ | NPY2R | P49146 | 4/20 | 0.45 |
| ▸ | NPY5R | Q15761 | 4/20 | 0.45 |
| ▸ | NOD1 | Q9Y239 | 3/20 | 0.44 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.43 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.43 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.43 |
| ▸ | TERT | O14746 | 1/20 | 0.42 |
| ▸ | CD40 | P25942 | 1/20 | 0.40 |
| ▸ | NMT2 | O60551 | 1/20 | 0.40 |
| ▸ | NMT1 | P30419 | 1/20 | 0.40 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.39 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.39 |
| ▸ | CARM1 | Q86X55 | 1/20 | 0.39 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.39 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.39 |
| ▸ | PRMT7 | Q9NVM4 | 1/20 | 0.39 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.39 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8010124 | 1.00 | NPY4R (0.45) | NPY4RNPY1RNPY2RNPY5RNOD1 | |
| SCHEMBL31406583 | 0.97 | NOD1 (0.47) | NPY4RNPY1RNPY2RNPY5RNOD1 | |
| SCHEMBL30497050 | 0.97 | NOD1 (0.47) | NPY4RNPY1RNPY2RNPY5RNOD1 | |
| SCHEMBL30395232 | 0.96 | NPY4R (0.45) | NPY4RNPY1RNPY2RNPY5RNOD1 | |
| SCHEMBL31047157 | 0.95 | FOLH1 (0.48) | NPY4RNPY1RNPY2RNPY5RNOD1 | |
| SCHEMBL30063019 | 0.94 | NPY4R (0.42) | NPY4RNPY1RNPY2RNPY5RNOD1 | |
| SCHEMBL29378785 | 0.93 | FNTA (0.46) | NPY4RNPY1RNPY2RNPY5RNMT2 | |
| SCHEMBL31691755 | 0.93 | NPY4R (0.44) | NPY4RNPY1RNPY2RNPY5RGNAI3 | |
| SCHEMBL30880861 | 0.92 | FOLH1 (0.47) | NPY4RNPY1RNPY2RNPY5RNOD1 | |
| SCHEMBL31343396 | 0.92 | NPY4R (0.45) | NPY4RNPY1RNPY2RNPY5RNOD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11299509-B2 | Trigger-activatable sugar conjugates for cancer-selective labeling and targeting | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2022-04-12 | — | — | US | disclosed |
| WO-2000034473-A2 | SEVEN TRANSMEMBRANE DOMAIN RECEPTOR ZSIG56 | ZYMOGENETICS, INC. (US) | 2000-06-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11299509-B2 | Trigger-activatable sugar conjugates for cancer-selective labeling and targeting | FUT6, GPI, CSGALNACT1 | NPY4R 2404/4885NPY1R 2500/4885NPY2R 3646/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.